ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SLN vs VSTM // OPERATING MARGIN

Silence Therapeutics Plc American Depository Share (NASDAQ) VS. Verastem Inc. (NASDAQ) • 15-METRIC TALLY: SLN 4 — VSTM 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SLN VS. VSTM) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SLN VSTM SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 61.50% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -5.06% -11.72% +6.66 SLN /fcf-yield <GO>
Operating Margin ACTIVE -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -65.00% 180.00% -245.00 VSTM /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.36 0.20 +3.16 SLN /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 78.5 61.2 +17.30 SLN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.23B $1.18B $43.7M SLN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SLN REV VSTM REV SLN GROSS % VSTM GROSS % SLN FCF VSTM FCF
FY 2025 $559.0K $30.9M 61.5% — -$62.3M -$137.5M
FY 2024 $43.3M $10.0M 72.7% — -$67.9M -$104.8M
FY 2023 $31.6M $257.8M — — -$49.5M -$86.5M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SLN // BETA —
VSTM // BETA —